WFDC2 and ovarian carcinoma: Neither biomarkers (CA125 or HE4) alone nor TVS alone performed well, bringing into question the sequence of tests (CA125 followed by TVS) in the UK National Institute for Health and Care Excellence guidance for detection of ovarian cancer in primary care, especially in women older than 50 years.